CN101129384A - 一种制备卡马西平缓释胶囊的方法 - Google Patents
一种制备卡马西平缓释胶囊的方法 Download PDFInfo
- Publication number
- CN101129384A CN101129384A CNA2007101457688A CN200710145768A CN101129384A CN 101129384 A CN101129384 A CN 101129384A CN A2007101457688 A CNA2007101457688 A CN A2007101457688A CN 200710145768 A CN200710145768 A CN 200710145768A CN 101129384 A CN101129384 A CN 101129384A
- Authority
- CN
- China
- Prior art keywords
- carbamazepine
- release
- hours
- capsules
- preparation technique
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Landscapes
- Medicinal Preparation (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
Description
产品 | 2小时 | 4小时 | 8小时 |
实施例1 | 40.4% | 62.0% | 91.9% |
实施例2 | 43.1% | 66.0% | 89.8% |
实施例3 | 37.6% | 61.6% | 93.2% |
溶出介质 | 2小时 | 4小时 | 8小时 |
PH=1.2的盐酸溶液 | 32.1% | 53.4% | 78.6% |
PH=4.0醋酸盐缓冲液 | 40.4% | 58.6% | 87.5% |
PH=6.8磷酸盐缓冲液 | 37.9% | 61.5% | 90.4% |
水 | 43.2% | 64.5% | 84.9% |
Claims (8)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN2007101457688A CN101129384B (zh) | 2007-09-06 | 2007-09-06 | 一种制备卡马西平缓释胶囊的方法 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN2007101457688A CN101129384B (zh) | 2007-09-06 | 2007-09-06 | 一种制备卡马西平缓释胶囊的方法 |
Publications (2)
Publication Number | Publication Date |
---|---|
CN101129384A true CN101129384A (zh) | 2008-02-27 |
CN101129384B CN101129384B (zh) | 2011-07-20 |
Family
ID=39126894
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN2007101457688A Active CN101129384B (zh) | 2007-09-06 | 2007-09-06 | 一种制备卡马西平缓释胶囊的方法 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN101129384B (zh) |
Cited By (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2011077451A2 (en) * | 2009-12-22 | 2011-06-30 | Abbott Healthcare Private Limited | Controlled release pharmaceutical composition |
CN101647784B (zh) * | 2008-08-15 | 2012-04-11 | 北京科信必成医药科技发展有限公司 | 卡马西平缓释片及其制备方法 |
CN101711739B (zh) * | 2008-10-08 | 2012-07-04 | 中国人民解放军军事医学科学院毒物药物研究所 | 卡马西平的口服药物组合物 |
CN103961331A (zh) * | 2014-04-22 | 2014-08-06 | 青岛市中心医院 | 一种卡马西平口服胶囊及其制备方法 |
CN111388454A (zh) * | 2020-04-05 | 2020-07-10 | 刘立新 | 一种消化道定时崩解胶囊及其生产工艺 |
CN113244197A (zh) * | 2021-05-24 | 2021-08-13 | 天方药业有限公司 | 一种卡马西平缓释胶囊剂及其制备方法 |
Family Cites Families (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6162466A (en) * | 1999-04-15 | 2000-12-19 | Taro Pharmaceutical Industries Ltd. | Sustained release formulation of carbamazepine |
US6338857B1 (en) * | 2000-05-26 | 2002-01-15 | Pharma Pass Llc | Sustained release carbamazepine pharmaceutical composition free of food effect and a method for alleviating food effect in drug release |
-
2007
- 2007-09-06 CN CN2007101457688A patent/CN101129384B/zh active Active
Cited By (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN101647784B (zh) * | 2008-08-15 | 2012-04-11 | 北京科信必成医药科技发展有限公司 | 卡马西平缓释片及其制备方法 |
CN101711739B (zh) * | 2008-10-08 | 2012-07-04 | 中国人民解放军军事医学科学院毒物药物研究所 | 卡马西平的口服药物组合物 |
WO2011077451A2 (en) * | 2009-12-22 | 2011-06-30 | Abbott Healthcare Private Limited | Controlled release pharmaceutical composition |
WO2011077451A3 (en) * | 2009-12-22 | 2011-10-06 | Abbott Healthcare Private Limited | Controlled release pharmaceutical composition |
CN103961331A (zh) * | 2014-04-22 | 2014-08-06 | 青岛市中心医院 | 一种卡马西平口服胶囊及其制备方法 |
CN111388454A (zh) * | 2020-04-05 | 2020-07-10 | 刘立新 | 一种消化道定时崩解胶囊及其生产工艺 |
CN113244197A (zh) * | 2021-05-24 | 2021-08-13 | 天方药业有限公司 | 一种卡马西平缓释胶囊剂及其制备方法 |
CN113244197B (zh) * | 2021-05-24 | 2023-02-28 | 天方药业有限公司 | 一种卡马西平缓释胶囊剂及其制备方法 |
Also Published As
Publication number | Publication date |
---|---|
CN101129384B (zh) | 2011-07-20 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CA2322644C (en) | Pharmaceutical composition of topiramate | |
CN101129384B (zh) | 一种制备卡马西平缓释胶囊的方法 | |
CN101375869B (zh) | 含银杏叶提取物缓/控释微丸组合物及其制备方法 | |
PL200273B1 (pl) | Zastosowanie okskarbazepiny | |
CN104997735A (zh) | 盐酸小檗碱掩味微丸及其制剂 | |
JP2009137956A (ja) | 塩酸ファスジルの経口徐放性製剤 | |
CN111904942B (zh) | 一种托吡酯干混悬剂、制备方法及其应用 | |
NO339720B1 (no) | Sakte frigivende sammensetning, fremgangsmåte for fremstilling derav og anvendelse av samme | |
US4966770A (en) | Prednisone microencapsulated granules | |
CN104997748B (zh) | 一种治疗高血压急症的硝苯地平缓释片剂及其制备工艺 | |
CA3169665A1 (en) | Pharmaceutical composition comprising dapagliflozin | |
CN103655480A (zh) | 一种美托洛尔的缓释药物组合物及其制备方法 | |
CN105434398B (zh) | 一种雷贝拉唑肠溶微丸及其制备方法 | |
CN102743357A (zh) | 一种普瑞巴林胃内泡腾漂浮缓释制剂及其制备方法 | |
CN1529587B (zh) | 含有粪便软化剂泊洛沙姆和包有肠溶衣的比沙可定颗粒的药物组合物 | |
CN102138906B (zh) | 一种盐酸可乐定缓释微丸制剂 | |
CN107441051B (zh) | 一种盐酸普罗帕酮微片及其制备方法 | |
CN102247326B (zh) | 一种普萘洛尔及其盐类口服择时控释微丸制剂 | |
CN101099762A (zh) | 珍菊降压缓释制剂 | |
CN115671054A (zh) | 一种甘露醇丸芯及其制备方法与应用 | |
CN101961324A (zh) | 一种依托贝特缓释胶囊的处方及制备方法 | |
CN102657615A (zh) | 一种长春胺缓释微丸制剂及其制备方法 | |
CN104274444B (zh) | 达比加群酯或其盐的口服双微丸药物组合物 | |
CN101879139A (zh) | 一种治疗消化性疾病的肠溶制剂及其制备方法 | |
CN104758273A (zh) | 一种尿素微囊制剂及其制备方法 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
ASS | Succession or assignment of patent right |
Owner name: SHANGHAI PUKANG PHARMACEUTICAL CO., LTD. |
|
C41 | Transfer of patent application or patent right or utility model | ||
TA01 | Transfer of patent application right |
Effective date of registration: 20110601 Address after: 463000 No. 2 Guangming Road, Henan, Zhumadian Applicant after: Tianfang Pharmaceutical Co., Ltd., Henan Co-applicant after: Shanghai Pukang Pharmaceutical Co., Ltd. Address before: 463000 No. 2 Guangming Road, Henan, Zhumadian Applicant before: Tianfang Pharmaceutical Co., Ltd., Henan |
|
C14 | Grant of patent or utility model | ||
GR01 | Patent grant | ||
ASS | Succession or assignment of patent right |
Owner name: TOPFOND PHARMACEUTICAL CO., LTD. Free format text: FORMER OWNER: TIANFANG PHARMACEUTICAL CO., LTD., HENAN Effective date: 20141231 |
|
C41 | Transfer of patent application or patent right or utility model | ||
TR01 | Transfer of patent right |
Effective date of registration: 20141231 Address after: Zhumadian City, Henan province 463000 Guangming Road Yicheng District No. 2 Patentee after: TIANFANG PHARMACEUTICAL CO., LTD. Patentee after: Shanghai Pukang Pharmaceutical Co., Ltd. Address before: 463000 No. 2 Guangming Road, Henan, Zhumadian Patentee before: Tianfang Pharmaceutical Co., Ltd., Henan Patentee before: Shanghai Pukang Pharmaceutical Co., Ltd. |